Description

Bacteriostatic Water and 3 R-TA 3G (GLP-3) 10mgs supplied as a purified research peptide in lyophilized powder form. Each vial is sealed for integrity and stability. This material is intended exclusively for laboratory research, analytical testing, and scientific study.

Handling: Store in a cool, dry environment. Protect from direct sunlight and moisture.

Disclaimer: This product is furnished strictly for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or household use.

What is RDAmd GLP-3 R?

RDAmd GLP-3 R is a synthetic research peptide designed as a
triple receptor agonist targeting the GLP-1, GIP, and
glucagon receptors—pathways involved in energy regulation, glucose metabolism, and appetite signaling
in experimental models.

Research Use Only
Triple-Pathway Targeting
99%+ Purity (COA)

Appetite Regulation (Research Models)

By stimulating GLP-1 and GIP receptors, GLP-3 R may influence satiety signaling pathways and gastric emptying dynamics
observed in non-clinical research.

Blood Sugar Modulation (Research Models)

Preclinical research suggests triple-agonist signaling can impact glucose tolerance by influencing insulin secretion
and glucagon dynamics in response to nutrient intake.

Energy Metabolism (Research Models)

Glucagon receptor activity is associated with energy expenditure and lipolysis pathways—one reason triple agonists
are studied for durable metabolic effects in experimental systems.

Research Applications

Non-clinical and preclinical use cases commonly explored for tri-agonist signaling.

Weight Management Studies

Investigated for combined effects on food intake signaling and energy expenditure pathways in diet-induced
obesity models.

Metabolic Function Research

Used to study glucose handling, insulin sensitivity, lipid metabolism, and hepatic fat dynamics in controlled
experimental settings.

Hormonal Cross-Talk

Enables researchers to dissect GLP-1/GIP/glucagon interactions across tissues such as pancreas, liver, adipose,
and brain.

Note: This product is intended for laboratory research only and is not approved for human or veterinary use.

Peptide Characteristics

Reference identifiers and handling notes for lab workflows.

Chemical Formula

C223H343F3N46O70

Molecular Weight

4731.34 g/mol

CAS Number

2381089-83-2

PubChem SID

474492235

Synonyms

LY3437943; Triple Agonist GLP-1/GIP/Glucagon Analog

Amino Acid Sequence

Not publicly disclosed (proprietary to specific research programs).

Contents & Storage

Packaging format and storage guidance for preserving integrity.

Available Contents

10mg / 20 mg / 30mg lyophilized (freeze-dried) powder in a sterile sealed 3 ml vial.

Purity

>99% (Third-party testing; COA available).

Storage (Sealed)

Store at ≤8°C, sealed, away from heat/light/moisture. Colder is generally preferred for long-term storage.

Handling Notes

Avoid repeated freeze-thaw cycles to help maintain integrity.

Research-only reminder: No dosage schedule is established outside regulated studies. Any dosing language belongs only to controlled research protocols—not consumer use.

GLP-3 R Overview

At-a-glance summary for product-page clarity.

Attribute RDAmd GLP-3 R
Type Triple receptor agonist (GLP-1 / GIP / Glucagon)
Primary Research Focus Appetite signaling, glucose regulation pathways, energy expenditure mechanisms
Mechanism Complexity Multi-pathway (triple-agonist signaling)
Regulatory Status Investigational / Research use only (not approved for human or veterinary use)
Format Lyophilized powder in sealed sterile vial (see Contents & Storage)

COA & Legal Disclaimer

Transparency for reproducibility + strict research-use positioning.

Certificate of Analysis (COA)

Each batch is third-party tested to verify purity and identity. A batch-specific COA is available upon request
to support documentation and reproducibility.

Legal Disclaimer

Intended for laboratory research only. Not for human or veterinary use. Not for diagnostic, therapeutic, or resale applications.

Additional information

Weight 0.2 lbs